Nevro Obtains $48,000,000 Series C Funding Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=c62d7f03-f3cb-4996-87ff-29289e49ff29&Preview=1 -
Date
3/7/2013 -
Company Name
Nevro -
Mailing Address
4040 Campbell Avenue Menlo Park, CA 94025 -
Company Description
Nevro is a medical device company developing novel neuromodulation therapies for multiple indications. The company’s initial focus is the development of an implantable device for the treatment of chronic pain. -
Website
http://www.nevrocorp.com -
Transaction Type
Venture Equity -
Transaction Amount
$48,000,000 -
Transaction Round
Series C -
Proceeds Purposes
The funds will be used to sponsor the ongoing U.S. pivotal clinical study, invest in clinical evidence for new indications and support the company’s international and U.S. commercialization plans. -
M&A Terms
-
Venture Investor
Novo Ventures -
Venture Investor
New Enterprise Associates -
Venture Investor
Covidien Ventures -
Venture Investor
Accuitive Medical Ventures -
Venture Investor
Bay City Capital -
Venture Investor
Johnson & Johnson Development Corporation -
Venture Investor
Mayo Medical Ventures -
Venture Investor
MPM Capital -
Venture Investor
Three Arch Partners
